|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/155 | |||
| C07K 14/005 | |||
| C07K 16/10 |
| (11) | Number of the document | 2453918 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10734875.7 |
| Date of filing the European patent application | 2010-07-15 | |
| (97) | Date of publication of the European application | 2012-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-12-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/042161 |
| Date | 2010-07-15 |
| (87) | Number | WO 2011/008974 |
| Date | 2011-01-20 |
| (30) | Number | Date | Country code |
| 225805 P | 2009-07-15 | US | |
| 294426 P | 2010-01-12 | US |
| (72) |
SWANSON, Kurt, US
DORMITZER, Philip, R., US
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME |
| RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME |